• Michael J Fox Foundation funds ketamine trial to treat patients with PD, depression

    1 month ago - By Healio

    The Michael J. Fox Foundation for Parkinson's Research awarded $2 million to a pair of researchers at Yale University for a clinical trial involving ketamine to treat depression in patients with Parkinson's disease.
    “This is the first investigation of ketamine as an antidepressant in a neurological disorder," John H. Krystal, MD, chair of the Yale Department of Psychiatry, said in a press release announcing the grant. "Results of this seminal trial could pave the way for a new generation of treatments for psychiatric symptoms in neurology.”
    Sophie E. Holmes, PhD,
    Read more ...